25:11

ToPIC: Building a CMT Guidance Document for the FDA

28:03

From Bench to Bedside: The Development of a Gene Therapy for Spinal Muscular Dystrophy

19:03

"The Making of an Investment Banker," With Jim Donovan

26:06

The SARM1 Axon Degeneration Pathway: The Journey from Academic Lab to Small Biotech to Big Pharma

22:32

Preparing for Clinical Trials in CMT2C: Challenges, Insights, and Unanswered Questions